Clinical Trial Results:
A randomised, parallel-group, double-blind, placebo-controlled Phase III trial assessing the efficacy and safety of ALK Grass Tablet Phleum pratense in subjects with seasonal grass pollen induced rhinoconjunctivitis
Summary
|
|
EudraCT number |
2004-000083-27 |
Trial protocol |
SE IT ES AT GB |
Global completion date |
26 Mar 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
13 Mar 2016
|
First version publication date |
13 Mar 2016
|
Other versions |
|
Summary report(s) |
GT-08 Synopsis GT-08 Extension Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.